Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Ding, Saidan ^a   Chen, Bicheng ^a   Zheng, Yong ^b   Lu, Qin ^a   Liu, Leping ^a   Zhuge, Qǐ Chuan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b People's Hospital of Ruian   (China)

Author keywords

OPRM1 gene; Polymorphisms; Schizophrenia

Indexed keywords

MU OPIATE RECEPTOR; OPRM1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU; SCHIZOPHRENIA;

EID: 84875859302     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-107     Document Type: Article

References (54)

1. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron 2006, 52(1):139-153. 10.1016/j.neuron.2006.09.015, 17015232.
2. Owen MJ, Craddock N, O'Donovan MC. Schizophrenia: genes at last?. Trends Genet 2005, 21(9):518-525. 10.1016/j.tig.2005.06.011, 16009449.
3. Caldwell CB, Gottesman I. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull 1990, 16(4):571-589. 10.1093/schbul/16.4.571, 2077636.
4. Doi N, Hoshi Y, Itokawa M, Usui C, Yoshikawa T, Tachikawa H. Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionaryviewpoint. PLoS One 2009, 4(11):e7799. 10.1371/journal.pone.0007799, 2772980, 19911060.
5. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165(4):497-506. 10.1176/appi.ajp.2007.07101573, 18198266.
6. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciūte D, Gennarelli M. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 2009, 5(2):e1000373. 10.1371/journal.pgen.1000373, 2631150, 19197363.
7. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40(9):1053-1055. 10.1038/ng.201, 18677311.
8. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543. 10.1126/science.1155174, 18369103.
9. Williams HJ, Owen MJ, O'Donovan MC. New findings from genetic association studies of schizophrenia. J Hum Genet 2009, 54(1):9-14. 10.1038/jhg.2008.7, 19158819.
10. Delfs JM, Kong H, Mestek A, Chen Y, Yu L, Reisine T, Chesselet MF. Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single celllevel. J Comp Neurol 1994, 345(1):46-68. 10.1002/cne.903450104, 8089277.
11. Uhl GR, Sora I, Wang Z. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA 1999, 96(14):7752-7755. 10.1073/pnas.96.14.7752, 33614, 10393893.
12. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking themu-opioid-receptor gene. Nature 1996, 383(6603):819-823. 10.1038/383819a0, 8893006.
13. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, Miner LL, Uhl GR. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci 1997, 94(4):1544-1549. 10.1073/pnas.94.4.1544, 19828, 9037090.
14. Ide S, Kobayashi H, Ujike H, Ozaki N, Sekine Y, Inada T, Harano M, Komiyama T, Yamada M, Iyo M. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms. Pharmacogenomics J 2006, 6(3):179-188. 10.1038/sj.tpj.6500355, 16402083.
15. Ide S, Kobayashi H, Tanaka K, Ujike H, Sekine Y, Ozaki N, Inada T, Harano M, Komiyama T, Yamada M. Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci 2004, 1025:316-324. 10.1196/annals.1316.039, 15542732.
16. Ikeda K, Ide S, Han W, Hayashida M, GR U, Sora I. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 2005, 26(6):311-317. 10.1016/j.tips.2005.04.001, 15925706.
17. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998, 95(16):9608-9613. 10.1073/pnas.95.16.9608, 21386, 9689128.
18. Ohmori O, Shinkai T, Hori H, Kojima H, Nakamura J. Polymorphisms of mu and delta opioid receptor genes and tardive dyskinesia in patients with schizophrenia. Schizophr Res 2001, 52(1-2):137-138.
19. Tan EC, Chong SA, Mahendran R, Tan CH, Teo YY. Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia. Schizophr Res 2003, 65(1):61-63. 10.1016/S0920-9964(02)00491-7, 14623376.
20. Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ. The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 2007, 103(1):77-87.
21. Bare L, Mansson E, Yang D. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett 1994, 354(2):213-216. 10.1016/0014-5793(94)01129-X, 7957926.
22. Pan L, Xu J, Yu R, Xu M, Pan Y, Pasternak G. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene. Oprm Neurosci 2005, 133(1):209-220.
23. Pan Y. Identification of alternatively spliced variants from opioid receptor genes. Meth Mol Med 2003, 84:65-75.
24. Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, Fish KN, Lewis DA. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry 2011, 168(9):921-929. 10.1176/appi.ajp.2011.11010052, 3273780, 21632647.
25. Fung SJ, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, Weickert CS. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing humanand in schizophrenia. Am J Psychiatry 2010, 167(12):1479-1488. 10.1176/appi.ajp.2010.09060784, 21041246.
26. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003, 23(15):6315-6326.
27. Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex ofsubjects with schizophrenia. Biol Psychiatry 2009, 65(12):1006-1014. 10.1016/j.biopsych.2008.11.019, 19121517.
28. Morris HM, Hashimoto T, Lewis DA. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects withschizophrenia or schizoaffective disorder. Cereb Cortex 2008, 18(7):1575-1587. 2888087, 18203698.
29. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, Murray RM, Poulton R, Moffitt TE. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry 2010, 167(2):160-169. 10.1176/appi.ajp.2009.09040574, 3552325, 20048021.
30. Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, Uema T, Takeda M, Amino N. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 2003, 141(1-2):155-164.
31. Trezza V, Damsteegt R, Achterberg EJ, Vanderschuren LJ. Nucleus accumbens μ-opioid receptors mediate social reward. J Neurosci 2011, 31(17):6362-6370. 10.1523/JNEUROSCI.5492-10.2011, 3098965, 21525276.
32. Volk DW, Radchenkova PV, Walker EM, Sengupta EJ, Lewis DA. Cortical Opioid Markers in Schizophrenia and across Postnatal Development. Cereb Cortex 2012, 22(5):1215-1223. 10.1093/cercor/bhr202, 21810780.
33. Tan EC, Chong SA, Mahendran R, Tan CH, Teo YY. Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patientswith schizophrenia. Schizophr Res 2003, 65(1):61-63. 10.1016/S0920-9964(02)00491-7, 14623376.
34. Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005, 280(38):32618-32624. 10.1074/jbc.M504942200, 16046395.
35. Goswami S, Mattoo SK, Basu D, Singh G. Substance-abusing schizophrenics: do they self-medicate?. Am J Addict 2004, 13(2):139-150. 10.1080/10550490490435795, 15204665.
36. Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatr 1998, 13(1):26-34.
37. Alves TM, Pereira JC, Elkis H. The psychopathological factors of refractory schizophrenia. Rev Bras Psiquiatr 2005, 27(2):108-112. 10.1590/S1516-44462005000200007, 15962134.
38. Overall JE. Rating session. Video taped interviews and BPRS ratings. Psychopharmacol Bull 1975, 11(1):15.
39. Corrêa H, Duval F, Mokrani MC, Bailey P, Trémeau F, Staner L, Diep TS, Crocq MA, Macher JP. Serotonergic function and suicidal behavior in schizophrenia. Schizophr Res 2002, 56:75-85. 1-2, 10.1016/S0920-9964(01)00181-5, 12084422.
40. Zhang C, Fang Y, Xie B, Cheng W, Du Y, Wang D, Yu S. DNA methyltransferase 3B gene increases risk of early onset schizophrenia. Neurosci Lett 2009, 462(3):308-311. 10.1016/j.neulet.2009.06.085, 19576953.
41. Zhang C, Fang Y, Xie B, Cheng W, Du Y, Wang D, Yu S. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia. Psychiatr Res 2010, 177(3):350-353.
42. Kumra S, Charles Schulz S. Editorial: research progress in early-onset schizophrenia. Schizophr Bull 2008, 34(1):15-17. 2632382, 18048380.
43. Devylder JE, Lukens EP. Family history of schizophrenia as a risk factor for axis I psychiatric conditions. J Psychiatr Res 2013, 47(2):181-187. 10.1016/j.jpsychires.2012.09.023, 23102629.
44. Purcell S, Cherny S, Sham P. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19(1):149-150. 10.1093/bioinformatics/19.1.149, 12499305.
45. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15(2):97-98. 10.1038/sj.cr.7290272, 15740637.
46. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix.Heredity (Edinb). Heredity (Edinb) 2005, 95(3):221-227.
47. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74(4):765-769. 10.1086/383251, 1181954, 14997420.
48. Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, Zvartau E, Gelernter J. Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 2006, 15(6):807-819. 10.1093/hmg/ddl024, 3164878, 16476706.
49. Káradóttir R, Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145(4):1426-1438. 10.1016/j.neuroscience.2006.08.070, 2173944,2173944, 17049173.
50. Káradóttir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438(7071):1162-1166. 10.1038/nature04302, 1416283, 16372011.
51. Serý O, Prikryl R, Castulík L, St'astný F. A118G polymorphism of OPRM1 gene is associated with schizophrenia. J Mol Neurosci 2010, 41(1):219-222. 10.1007/s12031-010-9327-z, 20112002.
52. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000, 401:3-38.
53. Hoenicka J, Garrido E, Martínez I, Ponce G, Aragüés M, Rodríguez-Jiménez R, España-Serrano L, Alvira-Botero X, Santos JL, Rubio G. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(1):79-85.
54. Wang LH, Chen JY, Liou YJ, Wang YC, Lai IC, Liao DL, Chen CH. Association of missense variants of the PRKC, apoptosis, WT1, regulator (PAWR) gene with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(3):870-875. 10.1016/j.pnpbp.2008.01.003, 18281137.